Key result
Thrombolytic therapy in spontaneous coronary artery dissection may cause clinical deterioration due to bleeding into the dissected vessel wall, while medical treatment is associated with poorer survival.
Highlights the risks of thrombolytic therapy in young adults with acute myocardial infarction caused by spontaneous coronary artery dissection.
In the excellent case report and review by Osula et al, concerning acute myocardial infarction in young adults, comment was passed on the probable mechanism of the actual myocardial infarct described, and other possible causes were reviewed.1 The point made that the diagnosis of spontaneous coronary artery dissection is often made at postmortem is accepted. However in life myocardial infarction in the young, due to spontaneous coronary artery dissection, has been linked to both immunosuppression and hypertension.2,3 There are a number of similar case series reported in the literature and it is clear from these that the survival rate is less good in the patients treated medically.4 It is also clear that thrombolytic therapy in spontaneous coronary artery dissection is potentially a “double edged sword”. Authors reporting the deterioration of patients after treatment with thrombolytics have suggested that thrombolytic induced bleeding into the dissected vessel wall is the probable cause of the clinical deterioration.5,6 Osula et al do suggest that diagnostic coronary angiography be performed in all cases but do not specify timing.
No takes yet. Share an insight, caveat, or question.
G J Morgan-Hughes (2002) conducted a letter in Acute myocardial infarction in young adults (spontaneous coronary artery dissection). Thrombolytic therapy was evaluated. Thrombolytic therapy in spontaneous coronary artery dissection may cause clinical deterioration due to bleeding into the dissected vessel wall, while medical treatment is associated with poorer survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: